T2 Biosystems (NASDAQ:TTOO) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research report released on Wednesday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Trading Down 8.2 %

NASDAQ:TTOO opened at $0.11 on Wednesday. T2 Biosystems has a 1 year low of $0.06 and a 1 year high of $6.80. The firm has a 50 day moving average of $0.16 and a 200-day moving average of $0.69.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.